MONITORING OF DRUG RESISTANCE IN THERAPY-NAIVE HIV INFECTED PATIENTS AND DETECTION OF AFRICAN HIV SUBTYPES IN HUNGARY

被引:5
|
作者
Kanizsai, Szilvia [1 ]
Ghidan, A. [1 ]
Ujhelyi, Eszter [2 ]
Banhegyi, D. [2 ]
Nagy, K. [1 ]
机构
[1] Semmelweis Univ, Inst Med Microbiol, H-1085 Budapest, Hungary
[2] Szent Laszlo St Ladislas Hosp, Immunol Lab, Budapest, Hungary
关键词
HIV-1 drug resistant mutants; genotyping; therapy-naive HIV-infected patients; HIV-1; subtypes; CRF; IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE; RECOMBINATION; DIVERSITY; INHIBITORS; MUTATIONS; EMERGENCE; EVOLUTION; DYNAMICS; PROTEASE;
D O I
10.1556/AMicr.57.2010.1.5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mutations in the HIV-1 pol gene associated with resistance to antiretroviral drugs in therapy-nave Hungarian individuals transmitted as primary infection by their foreign sexual partners originated from African, Asian and other European countries had been analyzed. Drug resistance genotyping of HIV RT and PR genes were performed where mutations of 72 codons - among them 64 specific resistance codons representing 6 nucleoside reverse transcriptase inhibitor (NRTIs), 2 non-nucleoside reverse transcriptase inhibitor (NNRTIs) and 6 proteinase inhibitor (PRIs) drugs had been analyzed by Truegene HIV-1 Genotyping kit and OpenGene Sequencing System. Viral variants harboring resistance mutations in the pol gene were detected in 14% of the subjects. The highest rate of resistance to a single class of inhibitors was detected towards PR inhibitors (12%), followed by NRTI (8%) and NNRTI (5%). On the contrary, 25% of viruses transmitted by homosexual activity contained mutations led to resistance to NNRT. Viruses from 11 percent of cases were resistant to 2 classes of inhibitors, and 7 percent to three classes of inhibitors. Based upon sequence data non-B subtypes and CRFs were detected in more than 71% of cases. HIV-1 C (10.7%), HIV-F1 (7.2%) and HIV-1 G (3.6%) were detected as the more frequent subtypes. Among the HIV-1 recombinant viruses CRF02 AG variants were found more frequently (28.5%) followed by CRF06_cpx (17.8%) indicating penetration of non-B subtypes and recombinant African variants into Hungary, which raises serious clinical and public health consequences.
引用
收藏
页码:55 / 68
页数:14
相关论文
共 50 条
  • [1] EMERGENCE OF ANTIRETROVIRAL DRUG RESISTANCE IN THERAPY-NAIVE HIV INFECTED PATIENTS IN HUNGARY
    Juhasz, Emese
    Ghidan, A.
    Kemeny, B.
    Nagy, K.
    [J]. ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2008, 55 (04) : 383 - 394
  • [2] Performance of the VERSANT® HIV-1 Resistance Assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes
    Derdelinckx, I
    Van Laethem, K
    Maes, B
    Schrooten, Y
    De Schouwer, K
    De Wit, S
    Fransen, K
    Ribas, SG
    Moutschen, M
    Vaira, D
    Zissis, G
    Van Ranst, M
    Van Wijngaerden, E
    Vandamme, AM
    [J]. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2003, 39 (02): : 119 - 124
  • [3] Antiretroviral drug resistance in HIV-1 therapy-naive patients in Cuba
    Perez, Lissette
    Kouri, Vivian
    Aleman, Yoan
    Abrahantes, Yeisel
    Correa, Consuelo
    Aragones, Carlos
    Martinez, Orlando
    Perez, Jorge
    Fonseca, Carlos
    Campos, Jorge
    Alvarez, Delmis
    Schrooten, Yoeri
    Dekeersmaeker, Nathalie
    Imbrechts, Stijn
    Beheydt, Gertjan
    Vinken, Lore
    Soto, Yudira
    Alvarez, Alina
    Vandamme, Anne-Mieke
    Van Laethem, Kristel
    [J]. INFECTION GENETICS AND EVOLUTION, 2013, 16 : 144 - 150
  • [4] Prevalence of resistance mutations associated with integrase inhibitors in therapy-naive HIV-positive patients in Hungary
    Ay, Eva
    Pocskay, Agnes
    Lakatos, Botond
    Szlavik, Janos
    Mezei, Maria
    Minarovits, Janos
    [J]. ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2021, 68 (02) : 87 - 91
  • [5] Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response
    Derdelinckx, I
    Van Laethem, K
    Maes, B
    Schrooten, Y
    De Wit, SP
    Florence, E
    Fransen, K
    Ribas, SG
    Marissens, D
    Moutschen, M
    Vaira, D
    Zissis, G
    Van Ranst, M
    Van Wijngaerden, E
    Vandamme, AM
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 37 (05) : 1664 - 1666
  • [6] K103N mutation in antiretroviral therapy-naive African patients infected with HIV type 1
    Akinsete, O
    Hirigoyen, D
    Cartwright, C
    Schut, R
    Kantor, R
    Henry, K
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (04) : 575 - 578
  • [7] Presence of HIV drug resistance in antiretroviral therapy-naive and -experienced patients from Papua New Guinea
    Gare, Janet
    Ryan, Claire E.
    David, Matthew
    Timbi, Diana
    Kaima, Petronia
    Kombati, Zure
    Imara, Ulato
    Kelly-Hanku, Angela
    Siba, Peter M.
    Crowe, Suzanne M.
    Hearps, Anna C.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (08) : 2183 - 2186
  • [8] Presence of genotypic resistance to antiretroviral drugs in a cohort of therapy-naive HIV-1-infected Italian patients
    Re, MC
    Monari, P
    Borderi, M
    Tadolini, M
    Verucchi, G
    Vitone, F
    Spinosa, S
    La Placa, M
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 27 (03) : 315 - 316
  • [9] Primo and experienced HIV-1 drug resistance analysis connected with HIV-1 subtypes among HIV infected patients in Hungary
    Ujhelyi, E.
    Barbai, V. H.
    Szlavik, J.
    Banhegyi, D.
    Sarvari, C.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2009, 46 : S29 - S29
  • [10] Correlations between transmitted HIV-1 drug resistance mutations and the human leukocyte antigen alleles of therapy-naive HIV patients
    Schweitzer, F.
    Mueller, S. M.
    Daeumer, M.
    Kaiser, R.
    Oette, M.
    Lengauer, T.
    Harrer, T.
    [J]. ANTIVIRAL THERAPY, 2008, 13 (04) : A76 - A76